Using nanostructures known as dendrimers to deliver anti-inflammatory drugs across the blood-brain barrier, scientists have been able to improve the symptoms of cerebral palsy in animals. Though still preclinical, that approach, which could also find applications in neurodegenerative diseases, adds cerebral palsy to the growing list of neurodevelopmental disorders that can be at least partially reversed.